Platinum Investment Management Ltd
Source: SEC Form 13F · as of Mar 2026Platinum Investment Management Ltd holds 20 biotech & pharma companies tracked by BioSniper, totaling $54.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$54.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Terns Pharmaceuticals, Inc. (TERN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| TERNTerns Pharmaceuticals, Inc. | 110,734 | $5.8M |
| CNTACentessa Pharmaceuticals plc | 137,741 | $5.5M |
| APGEApogee Therapeutics, Inc. | 58,314 | $4.9M |
| IMVTImmunovant, Inc. | 181,774 | $4.5M |
| COGTCogent Biosciences, Inc. | 112,066 | $4.3M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 64,752 | $4.1M |
| BBIOBridgeBio Pharma, Inc. | 49,269 | $3.7M |
| GPCRStructure Therapeutics Inc. | 66,864 | $3.2M |
| RCUSArcus Biosciences, Inc. | 134,217 | $2.9M |
| ZYMEZymeworks Inc. | 105,184 | $2.6M |
| ROIVRoivant Sciences Ltd. | 92,397 | $2.6M |
| RVMDREVOLUTION MEDICINES, INC. | 20,813 | $2.0M |
| PRQRProQR Therapeutics N.V. | 1,235,514 | $2.0M |
| STOKStoke Therapeutics, Inc. | 40,815 | $1.3M |
| DFTXDefinium Therapeutics Inc. | 70,000 | $1.3M |
| CCCCC4 Therapeutics, Inc. | 384,766 | $1.0M |
| BCYCBICYCLE THERAPEUTICS PLC | 184,603 | $857K |
| ARVNARVINAS, INC. | 72,527 | $769K |
| ABSIAbsci Corporation | 237,764 | $713K |
| SKYESkye Bioscience, Inc. | 233,095 | $143K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.